A critical examination of drug policy reveals the stark contrast between progressive approaches, like those in Portugal, and the regressive stance taken by current U.S. officials. The discussion highlights the dangers of labeling safe alternatives, such as Kratom and CBD, as harmful substances, drawing attention to the ignorance surrounding these issues. The fear of returning to outdated "just say no" ideologies raises concerns about the future of drug regulation and public health.
